+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Hepatitis Drug"

From
From
Hepatic Disease Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Hepatic Disease Treatment Market Report and Forecast 2024-2032

  • Report
  • August 2024
  • 240 Pages
  • Global
From
Hepatitis C Drug Market - Product Thumbnail Image

Hepatitis C Drug Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
From
Global Markets for Infectious Disease Treatments - Product Thumbnail Image

Global Markets for Infectious Disease Treatments

  • Report
  • December 2021
  • 245 Pages
  • Global
From
From
Alcoholic Hepatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Alcoholic Hepatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Autoimmune Hepatitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Autoimmune Hepatitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Alcoholic Hepatitis Treatment Market Report and Forecast 2024-2032

  • Report
  • November 2023
  • 170 Pages
  • Global
From
From
From
From
From
Loading Indicator

The Hepatitis Drug market is a subset of the Infectious Diseases Drugs market, which includes treatments for a variety of illnesses caused by microorganisms. Hepatitis drugs are used to treat viral infections of the liver, including hepatitis A, B, and C. These drugs can be used to reduce symptoms, prevent further damage to the liver, and even cure the infection. Common treatments include antiviral medications, interferon, and direct-acting antivirals. The Hepatitis Drug market is highly competitive, with many companies offering treatments for different types of hepatitis. Some of the major players in the market include AbbVie, Gilead Sciences, Merck, Bristol-Myers Squibb, and Novartis. Other companies such as Cipla, Mylan, and Teva Pharmaceuticals also offer treatments for hepatitis. Show Less Read more